NuPathe needs to address additional FDA queries regarding the Migraine Patch
NuPathe said that the Food and Drug Administration (FDA) has sent a Complete Response Letter (CRL) to the company regarding
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine